Page last updated: 2024-10-15

2-hydroxyatrazine

Description

4-ethylamino-6-isopropylamino-1,3,5-triazin-2-ol : A monohydroxy-1,3,5-triazine that is atrazine in which the chloro group has been replaced by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID135398733
CHEBI ID18316
SCHEMBL ID637767
MeSH IDM0090236

Synonyms (46)

Synonym
hydroxydechloroatrazine
4-(ethylamino)-6-(isopropylamino)-s-triazin-2-ol
4-(ethylamino)-6-(isopropylamino)-1,3,5-triazin-2-ol
2-hydroxyatrazine
4-ethylamino-6-isopropylamino-1,3,5-triazin-2-ol
CHEBI:18316
C06552
hydroxyatrazine ,
4-(ethylamino)-2-hydroxy-6-(isopropylamino)-1,3,5-triazine
2163-68-0
atrazine-2-hydroxy, analytical standard
g 34048
4-(ethylamino)-6-((1-methylethyl)amino)-1,3,5-triazin-2(1h)-one
ccris 3556
1,3,5-triazin-2(1h)-one, 4-(ethylamino)-6-((1-methylethyl)amino)-
2-hydroxy-4-(ethylamino)-6-(isopropylamino)-s-triazine
2-(ethylamino)-6-(propan-2-ylamino)-1h-1,3,5-triazin-4-one
FT-0651063
unii-d9y04ela63
d9y04ela63 ,
s-triazin-2-ol, 4-(ethylamino)-6-(isopropylamino)-
AKOS006227661
2-hydroxy-4-ethylamino-6-isopropylamino-s-triazine
hydroxy atrazine
atrazine-2-hydroxy
AKOS015894689
SCHEMBL637767
2-ethylamino-4-hydroxy-6-isopropylamino-1,3,5-triazine
hydroxyatrazine, 2-
g-34048
1,3,5-triazin-2(1h)-one, 4-(ethylamino)-6-[(1-methylethyl)amino]-
4-(ethylamino)-6-(isopropylamino)-1,3,5-triazin-2(1h)-one #
DTXSID6037807
atrazine-2-hydroxy, pestanal(r), analytical standard
atrazine-2-hydroxy 100 microg/ml in methanol
atrazine-2-hydroxy 10 microg/ml in methanol
J-014195
atrazine tp3
okm ,
4-(ethylamino)-6-[(propan-2-yl)amino]-1,3,5-triazin-2-ol
Q27102992
1,3,5-triazin-2(1h)-one,4-(ethylamino)-6-[(1-methylethyl)amino]-
4-(ethylamino)-6-(propan-2-ylamino)-1h-1,3,5-triazin-2-one
atrazine-2-hydroxy solution, 100 microg/ml in methanol
EN300-4248735
4-(ethylamino)-6-[(propan-2-yl)amino]-1,2-dihydro-1,3,5-triazin-2-one

Dosage Studied

ExcerptReference
" Intracellular NE was significantly reduced at these same concentrations of deethylchlorotriazine at 24 h while the concentration of NE in PC12 cells exposed to deisopropylchlorotriazine was not altered at any dosage or time point measured."( Alteration of catecholamines in pheochromocytoma (PC12) cells in vitro by the metabolites of chlorotriazine herbicide.
Cooper, RL; Das, PC; McElroy, WK, 2001
)
" While no significant delays in pubertal development were observed in two separate dose-response studies with doses ranging up to 183 mg/kg (OH-ATR), a minor but statistically significant delay in the onset of puberty in a pilot study using OH-ATR raises the possibility that an effect might occur following exposure to higher doses."( Pubertal development in female Wistar rats following exposure to propazine and atrazine biotransformation by-products, diamino-S-chlorotriazine and hydroxyatrazine.
Cooper, RL; Ferrell, JM; Laws, SC; Stoker, TE, 2003
)
" Based on a previous study in our laboratory, males were dosed with 11."( Evaluation of hydroxyatrazine in the endocrine disruptor screening and testing program's male and female pubertal protocols.
Hallinger, DR; Seely, JC; Stoker, TE; Zorrilla, LM, 2013
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
marine xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
diamino-1,3,5-triazineAny member of the class of 1,3,5-triazines that consists of a 1,3,5-triazine skeleton substituted by two amino groups.
monohydroxy-1,3,5-triazine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]